lorlatinib [Ligand Id: 7476] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL3286830 (Lorbrena, Lorlatinib, Lorviqua, PF-06463922) |
|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| ALK receptor tyrosine kinase/ALK tyrosine kinase receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4247] [GtoPdb: 1839] [UniProtKB: Q9UM73] | ||||||||
| ChEMBL | Inhibition of L1196M mutant (unknown origin) | B | 8.09 | pKi | 8.2 | nM | Ki | Eur J Med Chem (2017) 134: 348-356 [PMID:28431340] |
| GtoPdb | Note that this is inhibition of the ALK L1196M mutant enzyme. | - | 9.15 | pKi | 0.7 | nM | Ki | J Med Chem (2014) 57: 4720-44 [PMID:24819116] |
| ChEMBL | Inhibition of ALK L1196M mutant (unknown origin) | B | 9.15 | pKi | 0.7 | nM | Ki | J Med Chem (2018) 61: 6401-6420 [PMID:29589935] |
| ChEMBL | Inhibition of ALK (unknown origin) | B | 9.15 | pKi | 0.7 | nM | Ki | Eur J Med Chem (2017) 134: 348-356 [PMID:28431340] |
| ChEMBL | Binding affinity to ALK L1196M mutant (unknown origin) assessed as inhibition constant | B | 9.15 | pKi | 0.7 | nM | Ki | RSC Med Chem (2024) 15: 399-415 [PMID:38389874] |
| ChEMBL | Inhibition of ALK L1196M mutant (unknown origin) | B | 9.15 | pKi | 0.7 | nM | Ki | ACS Med Chem Lett (2018) 9: 878-883 [PMID:30258534] |
| ChEMBL | Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay | B | 9.15 | pKi | 0.7 | nM | Ki | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| ChEMBL | Affinity Biochemical interaction (Microfluidic mobility shift assay) EUB0000690a ALK | B | 10.15 | pKi | <0.07 | nM | Ki | Affinity Biochemical Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay | B | 10.15 | pKi | <0.07 | nM | Ki | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| ChEMBL | Binding affinity to ALK (unknown origin) assessed as inhibition of constant | B | 10.15 | pKi | <0.07 | nM | Ki | RSC Med Chem (2024) 15: 399-415 [PMID:38389874] |
| ChEMBL | Inhibition of human EML4-fused ALK G1202R mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA | B | 7.11 | pIC50 | 77 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| ChEMBL | Inhibition of human EML4-fused ALK 1151Tins mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA | B | 7.42 | pIC50 | 38 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| ChEMBL | Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA | B | 7.68 | pIC50 | 21 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| ChEMBL | Inhibition of human EML4-fused ALK G1269A mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA | B | 7.82 | pIC50 | 15 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| ChEMBL | Inhibition of human EML4-fused ALK L1152R mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA | B | 8.05 | pIC50 | 9 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| ChEMBL | Inhibition of human EML4-fused ALK S1206Y mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA | B | 8.38 | pIC50 | 4.2 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| ChEMBL | Inhibition of human EML4-fused ALK C1156Y mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA | B | 8.8 | pIC50 | 1.6 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| ChEMBL | Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA | B | 8.89 | pIC50 | 1.3 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| ChEMBL | Affinity On-target Cellular interaction (ELISA (ALK phosphoryaltion in 3T3-EML4-ALK engineered cell lines)) EUB0000690a ALK | B | 8.89 | pIC50 | 1.3 | nM | IC50 | Affinity On-target Cellular Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Inhibition of human EML4-fused ALK F1174L mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA | B | 9.7 | pIC50 | 0.2 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| epidermal growth factor receptor/Epidermal growth factor receptor erbB1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL203] [GtoPdb: 1797] [UniProtKB: P00533] | ||||||||
| ChEMBL | Selectivity interaction (Z’-LYTE assay (SelectScreen Invitrogen)) EUB0000690a EGFR | B | 6.5 | pKi | 319 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Selectivity interaction (Z’-LYTE assay (SelectScreen Invitrogen)) EUB0000690a EGFR | B | 7.25 | pKi | 56 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
| protein tyrosine kinase 2/Focal adhesion kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2695] [GtoPdb: 2180] [UniProtKB: Q05397] | ||||||||
| ChEMBL | Selectivity interaction (Z’-LYTE assay (SelectScreen Invitrogen)) EUB0000690a PTK2 | B | 7.77 | pKi | 17 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Inhibition of PTK2 (unknown origin) by TR-FRET-based Z'-LYTE assay | B | 7.77 | pIC50 | 17 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| leukocyte receptor tyrosine kinase/Leukocyte tyrosine kinase receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5627] [GtoPdb: 1838] [UniProtKB: P29376] | ||||||||
| ChEMBL | Selectivity interaction (Z’-LYTE assay (SelectScreen Invitrogen)) EUB0000690a LTK | B | 8.57 | pKi | 2.7 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Inhibition of LTK (unknown origin) by TR-FRET-based Z'-LYTE assay | B | 8.57 | pIC50 | 2.7 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| neurotrophic receptor tyrosine kinase 1/Nerve growth factor receptor Trk-A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2815] [GtoPdb: 1817] [UniProtKB: P04629] | ||||||||
| ChEMBL | Selectivity interaction (Z’-LYTE assay (SelectScreen Invitrogen)) EUB0000690a NTRK1 | B | 7.62 | pKi | 24 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Inhibition of NRTK1 (unknown origin) by TR-FRET-based Z'-LYTE assay | B | 7.62 | pIC50 | 24 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| neurotrophic receptor tyrosine kinase 2/Neurotrophic tyrosine kinase receptor type 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4898] [GtoPdb: 1818] [UniProtKB: Q16620] | ||||||||
| ChEMBL | Inhibition of TRKB (unknown origin) by off-chip mobility shift assay | B | 7.64 | pKi | 23 | nM | Ki | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| ChEMBL | Inhibition of TrkB (unknown origin) | B | 7.64 | pKi | 23 | nM | Ki | Eur J Med Chem (2017) 134: 348-356 [PMID:28431340] |
| ChEMBL | Selectivity interaction (Z’-LYTE assay (SelectScreen Invitrogen)) EUB0000690a NTRK2 | B | 7.64 | pKi | 23 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
| neurotrophic receptor tyrosine kinase 3/NT-3 growth factor receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5608] [GtoPdb: 1819] [UniProtKB: Q16288] | ||||||||
| ChEMBL | Selectivity interaction (Z’-LYTE assay (SelectScreen Invitrogen)) EUB0000690a NTRK3 | B | 7.34 | pKi | 46 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Inhibition of NRTK3 (unknown origin) by TR-FRET-based Z'-LYTE assay | B | 7.34 | pIC50 | 46 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| protein tyrosine kinase 2 beta/Protein tyrosine kinase 2 beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5469] [GtoPdb: 2181] [UniProtKB: Q14289] | ||||||||
| ChEMBL | Selectivity interaction (Z’-LYTE assay (SelectScreen Invitrogen)) EUB0000690a PTK2B | B | 7.85 | pKi | 14 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Inhibition of PTK2B (unknown origin) by TR-FRET-based Z'-LYTE assay | B | 7.85 | pIC50 | 14 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| c-ros oncogene 1, receptor tyrosine kinase/Proto-oncogene tyrosine-protein kinase ROS in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5568] [GtoPdb: 1840] [UniProtKB: P08922] | ||||||||
| ChEMBL | Inhibition of ROS1 G2032R mutant (unknown origin) | B | 7.92 | pKi | 12 | nM | Ki | Eur J Med Chem (2017) 134: 348-356 [PMID:28431340] |
| ChEMBL | Inhibition of ROS1 L2026M mutant (unknown origin) | B | 10 | pKi | 0.1 | nM | Ki | Eur J Med Chem (2017) 134: 348-356 [PMID:28431340] |
| ChEMBL | Inhibition of ROS1 L2026M mutant (unknown origin) in presence of ATP by microfluidic mobility shift assay | B | 10 | pKi | 0.1 | nM | Ki | J Med Chem (2020) 63: 10726-10741 [PMID:32432477] |
| ChEMBL | Inhibition of wild type ROS1 (unknown origin) | B | 10.6 | pKi | <0.03 | nM | Ki | Eur J Med Chem (2017) 134: 348-356 [PMID:28431340] |
| ChEMBL | Inhibition of ROS1 (unknown origin) | B | 10.6 | pKi | <0.03 | nM | Ki | ACS Med Chem Lett (2018) 9: 878-883 [PMID:30258534] |
| ChEMBL | Affinity Biochemical interaction (Microfluidic mobility shift assay) EUB0000690a ROS1 | B | 10.6 | pKi | <0.03 | nM | Ki | Affinity Biochemical Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Inhibition of ROS1 (unknown origin) by off-chip mobility shift assay | B | 10.7 | pKi | <0.02 | nM | Ki | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| GtoPdb | - | - | 11.3 | pKi | 0 | nM | Ki | Mol Cancer Ther (2013) : A277 |
| ChEMBL | Affinity On-target Cellular interaction (Sandwich ELISA (cell-based ROS1-fusion assay)) EUB0000690a ROS1 | B | 9.28 | pIC50 | <0.53 | nM | IC50 | Affinity On-target Cellular Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Affinity Phenotypic Cellular interaction (Free plasma tumor growth inhibition assay) EUB0000690a ROS1 | F | 8.24 | pEC50 | 5.8 | nM | EC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomics Library wave 3 |
| tyrosine kinase non receptor 2/Tyrosine kinase non-receptor protein 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4599] [GtoPdb: 2246] [UniProtKB: Q07912] | ||||||||
| ChEMBL | Selectivity interaction (Z’-LYTE assay (SelectScreen Invitrogen)) EUB0000690a TNK2 | B | 7.77 | pKi | 17 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Inhibition of TNK2 (unknown origin) by TR-FRET-based Z'-LYTE assay | B | 7.77 | pIC50 | 17 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| FER tyrosine kinase/Tyrosine-protein kinase FER in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3982] [GtoPdb: 2022] [UniProtKB: P16591] | ||||||||
| ChEMBL | Selectivity interaction (Z’-LYTE assay (SelectScreen Invitrogen)) EUB0000690a FER | B | 8.48 | pKi | 3.3 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Inhibition of FER (unknown origin) by TR-FRET-based Z'-LYTE assay | B | 8.48 | pIC50 | 3.3 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| FES proto-oncogene, tyrosine kinase/Tyrosine-protein kinase FES in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5455] [GtoPdb: 2023] [UniProtKB: P07332] | ||||||||
| ChEMBL | Selectivity interaction (Z’-LYTE assay (SelectScreen Invitrogen)) EUB0000690a FES | B | 8.22 | pKi | 6 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
| GtoPdb | - | - | 8.22 | pIC50 | 6 | nM | IC50 | J Med Chem (2014) 57: 4720-44 [PMID:24819116] |
| ChEMBL | Inhibition of FES (unknown origin) by TR-FRET-based Z'-LYTE assay | B | 8.22 | pIC50 | 6 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| fyn related Src family tyrosine kinase/Tyrosine-protein kinase FRK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4223] [GtoPdb: 2025] [UniProtKB: P42685] | ||||||||
| ChEMBL | Selectivity interaction (Z’-LYTE assay (SelectScreen Invitrogen)) EUB0000690a FRK | B | 7.28 | pKi | 53 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
| ChEMBL | Inhibition of FRK (unknown origin) by TR-FRET-based Z'-LYTE assay | B | 7.28 | pIC50 | 53 | nM | IC50 | J Med Chem (2014) 57: 4720-4744 [PMID:24819116] |
| Janus kinase 2/Tyrosine-protein kinase JAK2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2971] [GtoPdb: 2048] [UniProtKB: O60674] | ||||||||
| ChEMBL | Selectivity interaction (Z’-LYTE assay (SelectScreen Invitrogen)) EUB0000690a JAK2 | B | 6.28 | pKi | 529 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
ChEMBL data shown on this page come from version 35:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
